USD
$0.00
(0.00%
)At Close (As of Sep 8, 2025)
$121.53M
Market Cap
-
P/E Ratio
-1.56
EPS
$6.88
52 Week High
$1.59
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$332K |
Total Revenue | $0 |
Cost Of Revenue | $332K |
Costof Goods And Services Sold | $332K |
Operating Income | -$49M |
Selling General And Administrative | $17M |
Research And Development | $32M |
Operating Expenses | $49M |
Investment Income Net | - |
Net Interest Income | $4.1M |
Interest Income | $4.1M |
Interest Expense | $4.2M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | -$8.7M |
Income Before Tax | -$45M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$45M |
Comprehensive Income Net Of Tax | - |
Ebit | -$40M |
Ebitda | -$49M |
Net Income | -$45M |
Field | Value (USD) |
---|---|
Total Assets | $181M |
Total Current Assets | $172M |
Cash And Cash Equivalents At Carrying Value | $163M |
Cash And Short Term Investments | $163M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $9.3M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $3.2M |
Intangible Assets Excluding Goodwill | $3.2M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $7.5M |
Other Current Assets | $1.9M |
Other Non Current Assets | - |
Total Liabilities | $14M |
Total Current Liabilities | $11M |
Current Accounts Payable | $4.4M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $2.2M |
Total Non Current Liabilities | $3.4M |
Capital Lease Obligations | $4.5M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $4.5M |
Other Current Liabilities | $4.3M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $167M |
Treasury Stock | - |
Retained Earnings | -$245M |
Common Stock | $35K |
Common Stock Shares Outstanding | $21M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$36M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $332K |
Capital Expenditures | $63K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $19M |
Cashflow From Financing | $140M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$45M |
Field | Value (USD) |
---|---|
Gross Profit | -$332K |
Total Revenue | $0 |
Cost Of Revenue | $332K |
Costof Goods And Services Sold | $332K |
Operating Income | -$49M |
Selling General And Administrative | $17M |
Research And Development | $32M |
Operating Expenses | $49M |
Investment Income Net | - |
Net Interest Income | $4.1M |
Interest Income | $4.1M |
Interest Expense | $4.2M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | -$8.7M |
Income Before Tax | -$45M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$45M |
Comprehensive Income Net Of Tax | - |
Ebit | -$40M |
Ebitda | -$49M |
Net Income | -$45M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to identifying and promoting transformative therapies for the treatment of cancer and rare diseases. The company is headquartered in New York, New York.